Reimbursement News
Reimbursement news and insurance coverage updates.
Senators Reintroduce Bill to Establish Medicare Coverage Pathway for MCED Tests
The bill would allow Medicare to cover MCED tests following approval by FDA and ensure their use would not impact coverage of traditional screenings.
CMS Contractor Novitas Rescinds Coverage for Multiple Cancer Genetic Tests
Novitas reviewed, analyzed, and published literature for a variety of genetic oncology tests and highlighted several that it claims are not medically reasonable or necessary.
Interpace Biosciences to Stop Offering Pancreatic Cancer Test After Losing CMS Reimbursement
Novitas said in its coverage determination that the test has not demonstrated incremental clinical value in the prognosis of pancreatic cysts and associated cancer.
CMS Contractor Proposes Noncoverage of Castle Biosciences Skin Cancer Test
The contractor said that the test has not yet demonstrated definitive value above the combination of available clinical, pathological, and staging criteria in accurate risk stratification.
UK's NICE Recommends Genetic Testing for Therapy Selection in Stroke Patients
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.